Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Yunying Medical

Request full access

Personalized oncology diagnostics and related reagent development

Huangpu, ChinaFounded 2015Biotech & Life Sciences

About Yunying Medical

Yunying Medical, founded in 2015, is a high-tech enterprise established by a group of returning overseas students, advocating for precision medicine in oncology. The company focuses on providing personalized molecular diagnosis services and developing related reagents for cancer treatment. It offers a comprehensive precision medicine solution that covers early screening, targeted drug testing, and integrated drug development, utilizing technologies like genetic mutation and methylation detection.

The company was co-founded by CEO Dr. Daoyun Zhang and CTO Dr. Ziying Gong. Dr. Zhang holds a Ph.D. from the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, and was a postdoctoral fellow at Johns Hopkins University School of Medicine. Dr. Gong, also a Ph.D. from the Shanghai Institutes for Biological Sciences, is a molecular genetics expert who has led the development of the company's core technologies such as DNAplus™, Alldetect™, and AllNGS™. The founding team also includes biologists and bioinformatics experts from institutions like Johns Hopkins University and the National Cancer Institute.

Yunying Medical serves healthcare professionals and has a technical service network covering over 1,000 hospitals across five major regions in China. The company operates NGS sequencing labs, PCR labs, molecular labs, a GMP workshop, and a medical testing laboratory. Its business model involves providing clinical diagnosis for targeted drug use and tumor treatment monitoring, having developed its own capture reagents for second-generation sequencing. The firm has received B-round funding and counts investors like Jintan Capital among its backers.

Source: Dealroom company data

At a glance

Status
Operational
Employees
9
Open positions
None listed
Dealroom signal
24.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Mar 2026 — — CUFE Rising Capital ↗
LATE VC✓Equity / VC Apr 2020 $14M $55M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Yunying Medical website traffic

Latest recorded traffic for Yunying Medical is 380 monthly website visits, up 8.6% over the last three months. Yunying Medical's team grew 0% over the past year.

Latest monthly visits380 3-month web change+8.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Yunying Medical in the Huangpu ecosystem

Live from Dealroom

The Yunying Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • CUFE Rising Capital
Employees 9 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Yunying Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Yunying Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.